Results

Total Results: 452 records

Showing results for "opioids".
Users also searched for: opioid

161. Management of Suspected Opioid Overdose with Naloxone by Emergency Medical Services Personnel | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/emt-naloxon/systematic-review
     November 27, 2017 - Current Page Topic Timeline Aug. 30, 2016 Topic Initiated Nov. 30, 2016 Research Protocol Nov. 27, 2017 Systematic Review Management of Suspected Opioid Overdose with Naloxone by Emergency Medical Services Personnel Systematic Review November 27, 2017 Download Main Document PDF 2.7 MB Related Files Do…

162. Methods Research Report: Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
     November 01, 2020 - For the July/August searches, the precision ranged from 0.5 percent (opioids) to 8 percent (nonpharmacologic … For the September/October searches, precision was lower across reviews, ranging from 0.2 percent (opioids … precision could be due in part to the breadth of the reviews: precision was lowest for a review on opioids … utility, observational studies, and a wide range of interventions and comparisons, including various opioids … Even though the machine learning classifier was least precise for the opioids review, the time savings

163. Appendixes A-I (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-appendices.pdf
     January 16, 2023 - Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid … Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from … Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain. … Opioids for chronic noncancer pain: a systematic review and meta-analysis. … Concomitant Cannabis abuse/dependence in patients treated with opioids for non-cancer pain.

164. Making Healthcare Safer IV: Opioid Stewardship | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mhs4-opioid-stewardship/protocol

165. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substanceabuse_hi_impact.pdf
     January 01, 2012 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 14: Substance Abuse Potential High Impact Interventions Report Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 …

166. Appendixes A-I: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
     April 01, 2022 - Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4 … Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4 … Opioids for chronic noncancer pain: a systematic review and meta-analysis. … The safety of medications used to treat peripheral neuropathic pain, part 2 (opioids, cannabinoids … Concomitant cannabis abuse/dependence in patients treated with opioids for non-cancer pain.

167. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lumbar-spondylolisthesis.pdf
     March 01, 2021 - Medication-related adverse events, defined as: • Adverse events related to use of medications, including NSAIDs, opioids … intervention (such as hospitalization or surgical intervention) within 30 days of treatment Use of opioids

168. White Paper: Standardized Library of Lumbar Spondylolisthesis Outcome Measures (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-lumbar-spondylolisthesis.pdf
     March 01, 2021 - Medication-related adverse events, defined as: • Adverse events related to use of medications, including NSAIDs, opioids … intervention (such as hospitalization or surgical intervention) within 30 days of treatment Use of opioids

169. Cannabis-App-F5-Table-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2.xlsx
     January 22, 2022 - discontinuation 49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001 Estimates of the odds ratio to cease opioids

170. Appendix-E-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5.xlsx
     November 04, 2021 - discontinuation 49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001 Estimates of the odds ratio to cease opioids

171. Cannabis-App-F5-Table-Surveillance-Report-2 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0.xlsx
     February 16, 2022 - discontinuation 49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001 Estimates of the odds ratio to cease opioids

172. Appendix-E-Table-E5 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Table-E5_0.xlsx
     November 04, 2021 - discontinuation 49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001 Estimates of the odds ratio to cease opioids

173. Cannabis-App-F5-Table-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f5-table-surveillance-report-2_0_0.xlsx
     February 16, 2022 - discontinuation 49.3% (2650/5373) vs. 72.3% (3887/5373) p<0.001 Estimates of the odds ratio to cease opioids

174. Research Protocol for Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/suda-final-protocol.pdf
     October 02, 2018 - 1 percent of youth between the ages of 12 and 17 reporting current opioid misuse.11 Youth who use opioids … 1 Substances considered: alcohol, cannabis, opioids, sedatives/hypnotics/anxiolytics, stimulants, inhalants … alcohol use in the college setting (we will include existing systematic reviews) o Cannabis o Opioids … Acamprosate • Disulfiram • Topiramate • Ondansetron  Cannabis • N-acetylcysteine (NAC)  Opioids

175. Retention Strategies for Medications for Addiction Treatment (MAT) in Adults with Opioid Use Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/retention-strategies-opioid-use-disorder
     May 08, 2019 - Retention Strategies for Medications for Addiction Treatment (MAT) in Adults with Opioid Use Disorder Timeline May 07, 2019 Topic Initiated May 08, 2019 Research Protocol A Rapid Evidence Review of Retention Strategies for Medications for Addiction Treatment…

176. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ah…

177. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - Opioid Overdose by Nonclinicians  Key Facts: Fatal opioid overdoses of both prescription and illicit opioids

178. App-E-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveill-report-1.xlsx
     January 01, 2021 - Table E-1. RCT QA Table E-1. RCT quality assessment Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-to-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…

179. App-E-Opioid-Chronic-Pain-Surveillance-Report-3 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-3.xlsx
     January 01, 2021 - Table E-1. RCT QA Table E-1. RCT quality assessment Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-To-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…

180. App-E-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-opioid-chronic-pain-surveillance-report-2.xlsx
     January 01, 2021 - Table E-1. RCT QA Table E-1. RCT quality assessment Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? Outcome Assessors Masked? Care Provider Masked? Patient Masked? Intention-To-Treat (ITT) Analysis Acceptable Levels of Overall Attrition and Between-Group Differences…